Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
-
EVBox Group Consolidates Its Global Leadership by Reaching the Milestone of 200,000 Installed Charge Ports Worldwide
-
Verve Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
-
John Hancock Hedged Equity & Income Fund Required Notice to Shareholders - Sources of Distribution Under Section 19(a)
-
Perella Weinberg to go public via $975-million deal with Betsy Cohen's SPAC
-
Perella Weinberg to Merge with SPAC FinTech Acquisition Corp. IV (FTIV)
-
Current becomes first fintech to receive government stimulus payments
-
Perella Weinberg Partners and FinTech IV Announce Execution of Definitive Business Combination Agreement
-
Stock-picking hedge funds land investors double-digit gains in 2020
-
Esports Player Skillz to Merge with SPAC Flying Eagle Acquisition (FEAC) to Come Public
-
Skillz Becomes First Publicly-Traded Mobile Esports Platform
-
CIIG Merger Corp. Announces Filing of a Registration Statement on Form F-4 by Arrival Group in Connection With Its Proposed Business Combination With Arrival S.à r.l.
-
ESCAPE Bio Appoints Edward Owens and Scott Morrison to Board of Directors
-
EVBox Group to Become Public Company via Business Combination with TPG Pace Beneficial Finance (TPGY)
-
EVBox Group to Become Public Company via Business Combination with TPG Pace Beneficial Finance
-
Cityblock Health Raises $160M Series C to Address Systemic Healthcare Inequity
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A TANDEM DIABETES CARE Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Syndax Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
-
Wellington Management Announces Close of Wellington Hadley Harbor III at US$1.8 Billion
-
BayBoston Announces Hiring of Andres Saldaña as General Counsel and the Retirement of Richard Toomey
-
Current Announces $131 Million in Series C funding; Surpasses 2 Million Members
-
Verve Therapeutics to Present at the Piper Sandler Annual Virtual Healthcare Conference
-
Butterfly Network to be listed on NYSE through merger with Longview Acquisition Corp. (LGVW)
-
Butterfly Network, a global leader in democratizing medical imaging, to be listed on NYSE through a merger with Longview Acquisition Corp.
-
UNCF Launches Wellington Management Foundation Scholarship Program
-
Arrival, the company creating electric vehicles with its game-changing technologies, to list on NASDAQ through merger with CIIG Merger Corp.
-
Arrival, the company creating electric vehicles with its game-changing technologies, to list on NASDAQ through merger with CIIG Merger Corp.
-
Morgan Stanley Launches the Institute for Inclusion
-
Arrival to list on NASDAQ through merger with CIIG Merger Corp. (CIIC)
-
Form 13F-HR WELLINGTON MANAGEMENT For: Sep 30
-
Vontobel Asset Management Strengthens Its Institutional Distribution in Key US Territory
-
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
-
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
-
What Are Good Penny Stocks To Buy Right Now? 4 For Your Watch List?
-
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
-
Form SC 13G StepStone Group Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Triton International Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MultiPlan Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G ChemoCentryx, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A MyoKardia, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Cinemark Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ADVANCED DRAINAGE SYSTEM Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Akebia Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Iterum Therapeutics plc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Verve Therapeutics Announces Presentations on its Gene Editing Approach to Develop Transformative Medicines for Coronary Heart Disease at the American Heart Association Scientific Sessions 2020
-
BGL Announces the Merger of Lordstown Motors Corporation with DiamondPeak Holdings Corporation in a Transaction Valued Over $1.6 Billion
-
LianBio Announces $310 Million Crossover Financing

